Article

Harnessing the lymphocyte meta-phenotype to optimize adoptive cell therapy

medRxiv · 2016 · Buttenschoen, A.; Elkenawi, A.; El Moustaid, F.; Fletcher, A.; Grassberger, C.; Kim, E.; Marusyk, A.; McClelland, H.-L.; Miroshnychenko, D.; Nichol, D.; Mullinax, J.; O'Farrely, C.; Scott, J.

Key facts

Title Harnessing the lymphocyte meta-phenotype to optimize adoptive cell therapy
First author Buttenschoen, A.; Elkenawi, A.; El Moustaid, F.; Fletcher, A.; Grassberger, C.; Kim, E.; Marusyk, A.; McClelland, H.-L.; Miroshnychenko, D.; Nichol, D.; Mullinax, J.; O'Farrely, C.; Scott, J.
Journal medRxiv
Published Nov 5, 2016
DOI 10.1101/085910
Devices mentioned 085910

At a glance

  • 1–9 FDA submissions mentioned
  • None Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature